The urokinase system in the pathogenesis of atherosclerosis.
about
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator.Extracellular matrix biomarker, fibulin-1, is closely related to NT-proBNP and soluble urokinase plasminogen activator receptor in patients with aortic valve stenosis (the SEAS study).High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis.Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events.Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor.Fibrinolysis and proliferative endarteritis: two related processes in chronic infections? The model of the blood-borne pathogen Dirofilaria immitis.The serum levels of MMP-9, MMP-2 and vWF in patients with low doses of urokinase peritoneal dialysis decreased uremia complicated with cerebral infarctionFirst-in-human uPAR PET: Imaging of Cancer Aggressiveness.Association among Fibrinolytic Proteins, Metabolic Syndrome Components, Insulin Secretion, and Resistance in Schoolchildren.Soluble Urokinase Receptor and Chronic Kidney Disease.Introduction of a prognostic biomarker to strengthen risk stratification of acutely admitted patients: rationale and design of the TRIAGE III cluster randomized interventional trial.Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor.Serum suPAR in patients with FSGS: trash or treasure?Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.Can the activation of plasminogen/plasmin system of the host by metabolic products of Dirofilaria immitis participate in heartworm disease endarteritis?Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction.Upregulation of CFTR in patients with endometriosis and its involvement in NFκB-uPAR dependent cell migration.Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Is Not Associated with Neurological Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage.Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients.Vitronectin and Urokinase-Type Plasminogen Activator Gene Expression Levels Are Increased in Patients with Coronary Artery In-Stent Restenosis.Ligand binding modulates the structural dynamics and activity of urokinase-type plasminogen activator: A possible mechanism of plasminogen activation.Use of a proximity extension assay proteomics chip to discover new biomarkers associated with albuminuria.uPAR signaling is under par for the podocyte course.Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans
P2860
Q33794163-44065FF4-50F2-4C5A-B90B-B26C2A45FF05Q33889897-FF0A1774-0A22-4FE8-987C-2EE1D0418D35Q34053623-6B22612F-6EE7-499C-9ACE-6FD9D7FFE59BQ35070791-28FD5D0E-1F5F-4750-BEC7-1A4915162BE9Q35152774-F1595FF8-9D54-4784-8AFE-A8D5F78C2169Q35393419-58706F0F-F43C-45F9-9ED9-3350EAA8D61BQ36182904-3D6769A2-64B6-49BD-887E-13C6EF7D429AQ36191589-49FFE5EF-02BF-45B6-8834-16F858739201Q36304590-D15558C2-EC7E-4E7F-A83E-8FE01D4D5B57Q36429637-B45912B7-CB81-4EB6-B7F3-1862B817F666Q37154114-63B22307-277A-4219-B750-F28966715E2DQ37577266-118AA623-896F-4EAD-AFFE-AC221356DCBCQ38091638-4CB180E8-968E-44B5-84CF-871F7FD377EEQ38747883-E98CB50E-DC08-4197-A0CA-F18DA7B676C2Q39437530-454A64A2-6358-47BF-A4CC-837E6CC8DDFBQ40114454-76072225-6376-4548-8C50-8D8FA707173DQ41028891-C2A16ED0-739C-4CCB-B5FC-9291035362F0Q42130797-C2C29F2E-A4F5-4227-A871-58812EDCF6D9Q42291229-6A14104F-B142-4B78-98B3-E9F125BC6793Q45306072-45D52DBE-CE80-4F3A-A0E0-9D703CEE4401Q49984918-2B2EB36B-9945-41AB-B2CB-BF28A25F543EQ50114294-388DCC7A-4347-4B66-AFEB-C57B9568A295Q50129204-6946DEF9-1669-4261-8467-E365B155159AQ52886054-DD86207E-F5EE-4042-B17D-EC543025D33DQ58130073-D0A7AAFE-87A6-4D88-BF40-DE1F22ACAC45
P2860
The urokinase system in the pathogenesis of atherosclerosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The urokinase system in the pathogenesis of atherosclerosis.
@en
The urokinase system in the pathogenesis of atherosclerosis.
@nl
type
label
The urokinase system in the pathogenesis of atherosclerosis.
@en
The urokinase system in the pathogenesis of atherosclerosis.
@nl
prefLabel
The urokinase system in the pathogenesis of atherosclerosis.
@en
The urokinase system in the pathogenesis of atherosclerosis.
@nl
P1433
P1476
The urokinase system in the pathogenesis of atherosclerosis.
@en
P2093
Bianca Fuhrman
P356
10.1016/J.ATHEROSCLEROSIS.2011.10.044
P577
2011-11-16T00:00:00Z